Calgary, AB – TheNewswire – March 24, 2022 – nDatalyze Corp. (“NDAT“or the”society”) (CSE:NDAT) (CNSX:NDAT.CN) (OTC: NDATF) is pleased to announce that the Company has engaged (the “Engagement”) RB Milestone Group LLC (“RBMG”), based in New York, to increase the Company’s visibility to investors.
NDAT President Jim Durward said, “We recently obtained an OTCQB listing in the United States to make it easier for US investors to trade our shares and with RBMG’s commitment, we are proactively moving to expand the investor exposure to a wider audience within the investment community in advance of our product’s planned release.”
The engagement includes RBMG providing the company with investor relations and corporate communications advisory services for an initial term of twelve monthss effective April 1, 2022. The fee associated with the engagement consists of 12 monthly cash payments of US$7,938.00 and will not receive any equity in the company as compensation.
Founded in 2009, RBMG is a US-based corporate communications firm specializing in investor relations consulting with offices in New York and Stamford, Connecticut. RBMG’s US advisory practice offers tailored investor relations programs for emerging companies that are private and publicly traded on the NYSE, NASDAQ, OTC, TSX, TSXV, CSE , ASX and AIM. RBMG refines communication strategies, weighs data and advises clients on how to enter new markets. He helps clients target and secure relationships with niche US players and key industry strategies globally. Using digital techniques, artificial intelligence (AI) and machine learning, RBMG has developed methods that enhance traditional client IR initiatives to maximize return on investment. RBMG partners with clients across a wide range of industry segments, including: cannabis; clean technologies; Consumer goods; Crypto; fintech; Health care; Metals and Mining; Professional services; Renewable energy; and technology. To learn more about RBMG, please visit: www.rbmilestone.com
About nDatalyze Corp. :
nDatalyze Corp. generates technological solutions related to health. The YMI division is developing a consumer mental health application based on machine learning and the MLdelic division is focusing on the application of machine learning to aid in the prediction of potential benefits associated with the use of entheogenic compounds in the mental health sector. Both YMI and MLdelic are based on the company’s proprietary reference database of over 1200 complete biometric records with EEG data “at the same time of day”. With facilities around the world, its Medxtractor division manufactures small-scale bio-extractors that are used to extract compounds from a variety of botanical biomasses. While the Medxtractor division is currently generating cash flow, the two YMI and MLdelic are in development and therefore the Company cannot accurately predict if or when these applications will become cash flow generating.
FOR MORE INFORMATION, PLEASE CONTACT:
James Durward, President and CEO
Phone: (403) 689-3901
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. This press release does not constitute an offer to sell or a solicitation of an offer to sell any securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “United States Securities Act”) or any state securities law and may not be offered or sold in the United States or to US persons unless registered under United States securities law and applicable state securities laws or an exemption from such registration is available.
The information in this press release includes certain information and statements about management’s views on future events, expectations, plans and prospects that constitute forward-looking statements. These statements are based on assumptions subject to significant risks and uncertainties. Due to these risks and uncertainties and due to various factors, actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward-looking statements. A number of factors could cause actual results to differ materially from these forward-looking statements and from future results. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it cannot guarantee that the expectations in the forward-looking statements will prove to be correct. Except as required by law, the Company disclaims any intention and undertakes no obligation to update or revise forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting these forward-looking statements or otherwise.